Takeda Pharmaceutical Co Ltd

(TKPHF)

By |

Profile

Takeda Pharmaceutical Co Ltd ("Takeda") is Japan's largest pharmaceutical company, with revenue of JPY 1,745 billion ($15 billion) in 2017. In January 2019, it closed its acquisition of Shire Plc ("Shire"), a diversified, Ireland-based specialty drug firm with $15 billion revenue in 2017, mostly derived from the U.S.. Management intends to focus future R&D and sales efforts on five core areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which comprise approximately 75% of revenue. Its geographic footprint will increase in the U.S. and diversify away from Japan, with pro-forma distribution expected to be about 48% U.S., 20% Japan, and 32% in the Rest of the World ("RoW").

Contact Information

Website: www.takeda.co.jp
Email: takeda.ir.contact@takeda.com
Main Phone: +81 662042111
Address: 4-1-1 Doshomachi
Address 2: Chuo-ku
City / Town: Osaka
Country: JPN
Postal Code: 540-8645

Issuer Information

Exchange: OTO
Employees: 27230
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Takeda Pharmaceutical Co Ltd ("Takeda") is Japan's largest pharmaceutical company, with revenue of JPY 1,745 billion ($15 billion) in 2017. In January 2019, it closed its acquisition of Shire Plc ("Shire"), a diversified, Ireland-based specialty drug firm with $15 billion revenue in 2017, mostly derived from the U.S.. Management intends to focus future R&D and sales efforts on five core areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which comprise approximately 75% of revenue. Its geographic footprint will increase in the U.S. and diversify away from Japan, with pro-forma distribution expected to be about 48% U.S., 20% Japan, and 32% in the Rest of the World ("RoW").

Contact Information

Website: www.takeda.co.jp
Email: takeda.ir.contact@takeda.com
Main Phone: +81 662042111
Address: 4-1-1 Doshomachi
Address 2: Chuo-ku
City / Town: Osaka
Country: JPN
Postal Code: 540-8645

Issuer Information

Exchange: OTO
Employees: 27230
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 35.40 $ 0.48 (1.37%)
Last Price 35.40 Change $ 0.48 Change % 1.37 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 35.40 High 35.40 Low 35.40 Prev Close 34.92
Last Trade Volume 895 52 Wk Hi 43.70 52 Wk Low 31.22
Market Cap 55.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,576,356,908.00 EPS (TTM) 1.39 PE Ratio 35.50 Exchange OTCPK